Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunoglobulins--merely expensive or also useful?]

W D Paar1

  • 1Medizinische Klinik und Poliklinik, Universität Bonn.

Therapeutische Umschau. Revue Therapeutique
|October 1, 1995
PubMed
Summary

Intravenous immune globulin (IVIG) is a primary treatment for immunodeficiency, preventing infections. IVIG also shows potential benefits for certain autoimmune diseases when other therapies fail.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One-year safety and quality of life outcomes in patients with atrial fibrillation on dronedarone: prospective, non-interventional study in German ambulatory care.

Herzschrittmachertherapie & Elektrophysiologie·2015
Same author

[Low molecular weight heparin in patients with impaired renal function].

Der Internist·2012
Same author

Labelling studies for structure elucidation of a new hydroxymetabolite of tramadol.

Isotopes in environmental and health studies·2011
Same author

A global perspective on blood pressure treatment and control in a referred cohort of hypertensive patients.

Journal of clinical hypertension (Greenwich, Conn.)·2010
Same author

[Subclinical albuminuria, microalbuminuria and proteinuria--accepted cardiovascular risk markers?].

Deutsche medizinische Wochenschrift (1946)·2006
Same author

Determination of the newer quinolones levofloxacin and moxifloxacin in plasma by high-performance liquid chromatography with fluorescence detection.

Journal of chromatographic science·2006

Area of Science:

  • Immunology
  • Therapeutics

Context:

  • Intravenous immune globulin (IVIG) therapy has been established for over 15 years.
  • Initially used for primary immunodeficiency diseases, IVIG replaces deficient antibodies to prevent infections.

Purpose:

  • To review the current status of IVIG therapy in primary and secondary immunodeficiency states.
  • To explore potential indications for IVIG in autoimmune diseases.

Summary:

  • IVIG is the treatment of choice for many immunodeficiency states.
  • Observations of increased platelet counts in specific conditions suggest immunomodulatory effects.
  • While not a first-line treatment for autoimmune diseases, IVIG may be beneficial when conventional therapies are ineffective.

Impact:

  • IVIG therapy is crucial for managing primary and secondary immunodeficiencies.
  • Further research into IVIG's immunomodulatory mechanisms could expand its therapeutic applications in autoimmune conditions.

Related Experiment Videos